Status:
COMPLETED
Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Barrett's Esophagus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is being done to test the feasibility and tolerability of a SECM imaging probe in patients with Barrett's Esophagus (BE). Subjects will undergo SECM probe imaging while they are under consc...
Detailed Description
Subjects with a previous diagnosis of Barrett's Esophagus will be recruited in the study and undergo SECM probe imaging while using conscious sedation, pulse oximetry and blood pressure monitoring. Th...
Eligibility Criteria
Inclusion
- A previous diagnosis of Barrett's Esophagus
- Patients must be over the age of 18
- Patient must be able to give informed consent
Exclusion
- Subjects with any history of intestinal strictures
- OR subjects with a history of prior GI surgery
- OR subjects with a history of intestinal Crohn's disease.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT02210039
Start Date
June 1 2014
End Date
December 1 2014
Last Update
April 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General hospital
Boston, Massachusetts, United States, 02114